SciRhom
PrivateLast Round
Series A
Jul 9, 2024
Total Funding Raised
$105.28M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SciRhom operates in Healthcare & Life Sciences and is based in Planegg. Its latest recorded funding round was a Series A round in July 2024.
SciRhom is a biotechnology company that develops first-in-class therapeutic antibodies targeting iRhom2 to treat autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SciRhom Comparables
Compare SciRhom with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Johnson & Johnson | 69% | |
| AstraZeneca | 66% | |
| Shattuck Labs | 63% |
For institutional investors. Book with your work email.
SciRhom Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 9, 2024 | ||||
| Seed | Nov 30, 2021 | ||||
| Seed | Jan 12, 2021 | ||||
| Seed | Nov 5, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SciRhom Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MIG Capital | Series A |
| Andera Partners | Series A |
| MIG AG | Series A |
| Ventura Ace | Seed |
| Hadean Ventures | Series A |
| Wellington Partners | Series A |
| Bayern Kapital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 828% MoM, from 67 to 622.
- Apr 4, 2026
Monthly visitors grew 92% MoM.
For institutional investors. Book with your work email.
SciRhom Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SciRhom's valuation, stock price, and market status.
Is SciRhom a public or private company?
SciRhom is a private company.
What is the current stock price of SciRhom?
SciRhom is a private company, so its shares have no public market price. Caplight tracks SciRhom's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SciRhom worth (valuation)?
Valuation information for SciRhom is not publicly available.
Can I buy SciRhom stock?
SciRhom shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SciRhom's last funding round?
SciRhom's most recent funding round was Series A on July 9, 2024.
Who are the main investors in SciRhom?
Key investors in SciRhom include MIG Capital, Andera Partners, Hadean Ventures, Wellington Partners, Kurma Partners.
Will SciRhom IPO soon?
No public IPO plans have been announced for SciRhom.
How can I track SciRhom secondary market activity?
Caplight tracks bids, offers, and trades in SciRhom's shares on secondary markets.